-
IntroducedJun 12, 2025
-
Passed House
-
Passed Senate
-
Signed into Law
To improve supply chain resiliency for critical drug products with vulnerable supply chains and ensure that reserves of critical drugs and active pharmaceutical ingredients are maintained to prevent supply disruptions in the event of drug shortages or public health emergencies.
Last Action See all actions
House • Jun 12, 2025: Referred to the House Committee on Energy and Commerce.
Summary/Bill Text
Comments on HR 3955
Tweets
Whip Lists
Sponsors
Votes
Actions
- Jun 12, 2025 | House
- Introduced in House
- Referred to the House Committee on Energy and Commerce.
Bill Texts
Documents